Durdagi, S., Aksoydan, B., Dogan, B., Sahin, K., Shahraki, A., & Birgül-İyison, N. (2021). Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike Receptor-Binding Domain Bound with ACE2 COVID19 Target Proteins: A Virtual Drug Repurposing Study. chemRxiv.org. doi:10.26434/chemrxiv.12032712
Chicago ZitierstilDurdagi, Serdar, Busecan Aksoydan, Berna Dogan, Kader Sahin, Aida Shahraki, and Necla Birgül-İyison. "Screening of Clinically Approved and Investigation Drugs As Potential Inhibitors of SARS-CoV-2 Main Protease and Spike Receptor-Binding Domain Bound With ACE2 COVID19 Target Proteins: A Virtual Drug Repurposing Study." ChemRxiv.org 2021.
MLA ZitierstilDurdagi, Serdar, et al. "Screening of Clinically Approved and Investigation Drugs As Potential Inhibitors of SARS-CoV-2 Main Protease and Spike Receptor-Binding Domain Bound With ACE2 COVID19 Target Proteins: A Virtual Drug Repurposing Study." ChemRxiv.org 2021.